Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04144257

Title field or adapter rule

{'original_value': 'Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-30T23:06:05.402361+00:00

Published At

2026-10-15T00:00:00+00:00

Record Updated At

2026-10-15

Results Posted At

2026-10-15

Source Retrieved At

2026-10-30T22:08:18.663814+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Multiple Sclerosis"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-15", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT04144257"

protocolSection.identificationModule.officialTitle

"Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2026-10-15", "type": "ACTUAL"}

Study condition terms

• Multiple Sclerosis (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Subjects diagnosed with multiple sclerosis'], 'description': 'PET radiopharmaceutical. Subjects will undergo \\[F-18\\]PBR06-PET (microglial activation).', 'name': '[F-18]PBR06', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Subjects diagnosed with multiple sclerosis'], 'description': 'PET radiopharmaceutical. Subjects will undergo \\[C-11\\]MRB-PET (norepinephrine transporter binding).', 'name': '[C-11]Methylreboxetine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• [F-18]PBR06 (protocolSection.armsInterventionsModule.interventions[].name)
• [C-11]Methylreboxetine (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.